ArticleJournal of clinical pharmacology2015

Semaglutide, a once-weekly human GLP-1 analog, does not reduce the bioavailability of the combined oral contraceptive, ethinylestradiol/levonorgestrel.

Christoph Kapitza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.